Practitioner Characteristics, Diagnostic Accuracy Metrics and Discovering-Individual With Respect to 637 Melanomas Documented by 27 General Practitioners on the Skin Cancer Audit Research Database Publisher Pubmed



Coetzerbotha M¹ ; Jimenezbalcells C^{2, 3} ; Hay J⁴ ; Keir J¹ ; Rosendahl N⁵ ; Wilson T⁶ ; Clark S^{5, 7} ; Baade A⁸ ; Becker C^{9, 10} ; Bookallil L¹¹ ; Clifopoulos C¹ ; Dicker T¹ ; Denby MP¹² ; Duthie D¹³ Show All Authors
Source: Australasian Journal of Dermatology Published:2023

Abstract

Background and Objective: Knowledge of accuracy for melanoma diagnosis and melanoma discovering-individual in primary care is limited. We describe general practitioner (GP) characteristics and analyse defined diagnostic accuracy metrics for GPs in the current study comparing this with a previous study for GPs common to both, and we analyse the individual first discovering each melanoma as a lesion of concern. Methods: The characteristics and diagnostic accuracy of 27 Australasian GPs documenting 637 melanomas on the Skin Cancer Audit Research Database (SCARD) in 2013 were described and analysed. The number needed to treat (NNT) and percentage of melanomas that were in situ (percentage in situ) were analysed as surrogates for specificity and sensitivity, respectively. The discovering-individual was analysed according to patient age and sex and lesion Breslow thickness. Results: The average NNT and percentage in situ were 5.73% and 65.07%, respectively. For 21 GPs in both a 2008–2010 study and the current study, the NNT was 10.78 and 5.56, respectively (p = 0.0037). A consistent trend of decreasing NNT and increasing percentage in situ through increasingly subspecialised GP categories did not reach statistical significance. NNT trended high at ages and sites for which melanoma was rare. While the patient or family member was more likely to discover thick melanomas and melanomas in patients under 40 years, GPs discovered 73.9% of the melanomas as lesions of concern. Conclusions: GPs were the discovering-individuals for the majority of melanomas in the current study and their accuracy metrics compared favourably with published figures for dermatologists and GPs. © 2023 The Authors. Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.